These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 15230363)

  • 1. Do pharmacists' reports of adverse drug reactions reflect patients' concerns?
    van Grootheest K; van Puijenbroek EP; de Jong-van den Berg LT
    Pharm World Sci; 2004 Jun; 26(3):155-9. PubMed ID: 15230363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Direct reporting of side effects by the patient: favourable experience in the first year].
    van Grootheest AC; Passier JL; van Puijenbroek EP
    Ned Tijdschr Geneeskd; 2005 Mar; 149(10):529-33. PubMed ID: 15782689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does spontaneous adverse drug reactions' reporting differ between different reporters? A study in Toulouse Pharmacovigilance Centre.
    Nicol C; Moulis F; Bondon-Guitton E; Durrieu G; Montastruc JL; Bagheri H
    Therapie; 2019 Oct; 74(5):521-525. PubMed ID: 31029402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pharmacist involvement on patient reporting of adverse drug reactions: first Italian study.
    Leone R; Moretti U; D'Incau P; Conforti A; Magro L; Lora R; Velo G
    Drug Saf; 2013 Apr; 36(4):267-76. PubMed ID: 23475583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric adverse drug reactions in the paediatric population.
    Ekhart C; Vries T; Hunsel FV
    Arch Dis Child; 2020 Aug; 105(8):749-755. PubMed ID: 32060030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug reaction reporting by patients in the Netherlands: three years of experience.
    de Langen J; van Hunsel F; Passier A; de Jong-van den Berg L; van Grootheest K
    Drug Saf; 2008; 31(6):515-24. PubMed ID: 18484785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre.
    Watson S; Chandler RE; Taavola H; Härmark L; Grundmark B; Zekarias A; Star K; van Hunsel F
    Drug Saf; 2018 Feb; 41(2):203-212. PubMed ID: 28933055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADR related questions received by a telephone medicines information service and ADRs received by a spontaneous ADR reporting system: a comparison regarding patients and drugs.
    Egberts AC; de Koning FH; Meyboom RH; Leufkens HG
    Pharmacoepidemiol Drug Saf; 1997 Jul; 6(4):269-76. PubMed ID: 15073778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands.
    van der Hooft CS; Sturkenboom MC; van Grootheest K; Kingma HJ; Stricker BH
    Drug Saf; 2006; 29(2):161-8. PubMed ID: 16454543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
    Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of direct patient reported ADRs to drug safety signals in the Netherlands from 2010 to 2015.
    van Hunsel F; de Waal S; Härmark L
    Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):977-983. PubMed ID: 28524293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expectations for feedback in adverse drug reporting by healthcare professionals in the Netherlands.
    Oosterhuis I; van Hunsel FP; van Puijenbroek EP
    Drug Saf; 2012 Mar; 35(3):221-32. PubMed ID: 22201474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse Drug Reactions to Opioids: A Study in a National Pharmacovigilance Database.
    Gustafsson M; Matos C; Joaquim J; Scholl J; van Hunsel F
    Drug Saf; 2023 Nov; 46(11):1133-1148. PubMed ID: 37824028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug reactions in Nigerian children: a retrospective review of reports submitted to the Nigerian Pharmacovigilance Centre from 2005 to 2012.
    Obebi Cliff-Eribo K; Sammons H; Star K; Ralph Edwards I; Osakwe A; Choonara I
    Paediatr Int Child Health; 2016 Nov; 36(4):300-304. PubMed ID: 26384567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands.
    Dittrich ATM; Draaisma JMT; van Puijenbroek EP; Loo DMWMT
    Paediatr Drugs; 2020 Aug; 22(4):425-432. PubMed ID: 32557243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing patients' and healthcare professionals' ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an example.
    van Hunsel F; Passier A; van Grootheest K
    Br J Clin Pharmacol; 2009 May; 67(5):558-64. PubMed ID: 19552751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of medicines-Pharmacists' knowledge, practice, and attitudes toward pharmacovigilance and adverse drug reactions reporting process.
    Kopciuch D; Zaprutko T; Paczkowska A; Ratajczak P; Zielińska-Tomczak Ł; Kus K; Nowakowska E
    Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1543-1551. PubMed ID: 31148344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region.
    Irujo M; Beitia G; Bes-Rastrollo M; Figueiras A; Hernández-Díaz S; Lasheras B
    Drug Saf; 2007; 30(11):1073-82. PubMed ID: 17973543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Experiencing Adverse Drug Reactions on the Patient's Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands.
    Rolfes L; van Hunsel F; Taxis K; van Puijenbroek E
    Drug Saf; 2016 Aug; 39(8):769-76. PubMed ID: 27145946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.